Fulcrum Therapeutics Inc. (FULC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Fulcrum Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.75
+1.35% today
Market cap
$283M
Overall quality
56/100
Kronos AI 30-day
+0.1%
4 of 8 simulated paths end higher
Fulcrum Therapeutics Inc. (FULC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $283M. It trades at $3.75, up 1.35% today. Its overall quality score is 56 out of 100, ranked against the whole US market. 2 analysts' average target of $3.00 implies −20.0% from today's price. Kronos AI's 30-day forecast is +0.1% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.00 |
| Low – high | $3.00 – $3.00 |
| Analysts | 2 |
| Upside to average | −20.0% |
Kronos AI 30-day forecast
| Expected close | $3.71 (+0.1%) |
| Likely range | −3.1% … +1.7% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 42 |
| Solvency | 61 |
| Growth | 64 |
| Overall | 56 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.